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neurons and significantly lower (16.54% ± 7.33 s.e.m. versus 57.01% ± 4.85 s.e.m., P < 0.01) c-fos expression in POMC neurons compared to vehicle-treated controls (Fig. 1a,b) . The same treatment caused elevated food intake during the light cycle compared to vehicle controls (1 h: 0.17 ± 0.05 g versus 0.01 ± 0.01 g; 2 h: 0.21 ± 0.04 g versus 0.01 ± 0.01 g; 4 h: 0.31 ± 0.08 g versus 0.06 ± 0.04 g; 8 h: 0.46 ± 0.11 g versus 0.1 ± 0.08 g; P < 0.05, all values mean ± s.e.m.) (Fig. 1c) . These observations are in line with our earlier findings 1 , and they reveal that suppression of ROS inhibits POMC neuronal activity, as assessed by c-fos expression.
Next, we tested the effect of promotion of ROS generation on POMC neuronal activity ex vivo and feeding behavior in vivo. We conducted patch-clamp whole-cell electrophysiological recordings in slice preparations from POMC-GFP mice (mice that express tau-topaz green fluorescent protein under the transcriptional control of POMC genomic sequence by the use of a bacterial artificial chromosome (BAC)) with and without H 2 O 2 application. 1 µM H 2 O 2 depolarized POMC neurons (Fig. 1d) and increased the firing rate of these cells (Fig. 1d) . In line with these neurobiological effects in the arcuate nucleus, i.c.v. injection of 5 µM H 2 O 2 in 2 µl caused significantly less feeding (P < 0.01) of mice after an overnight fast compared to vehicle-injected controls (Fig. 1e) . This effect of H 2 O 2 on promotion of decreased feeding is in line with the effect of ROS in glucose sensing and experimental hypertriglyceridemia 12, 13 . Taken together, these observations provide evidence that ROS can be an acute regulator of POMC neuronal activity and that exogenous ROS administered to the brain can promote satiety in lean mice.
We next analyzed ROS levels in POMC cells using dihydroethidium (DHE; a substrate for fluorimetric detection of peroxidase as a readout for ROS) from mice with normal metabolism (fed and fasted wild-type mice) and from mice with impaired POMC neuronal activity (ob/ob and diet-induced obese (DIO) mice). We found the lowest level of DHE fluorescent particles in POMC neurons of ob/ob mice (4.96 ± 0.23 (s.e.m.) fluorescent particles per 10 µm 2 of cytosol) and wild-type mice that, following a previously reported protocol 10 , were fasted overnight (5.16 ± 0.48 (s.e.m.) fluorescent particles per 10 µm 2 of cytosol) (Fig. 1f,g ). In contrast, 48 h of leptin treatment 10 of ob/ob mice resulted in elevated DHE expression in POMC neurons compared to PBS-treated controls (16.25 ± 1.15 versus 7.5 ± 1.32 fluorescent particles in 10 µm 2 cytosol; P < 0.05, means ± s.e.m.). DHE fluorescent levels were significantly (P < 0.001) higher in fed wild-type animals (14.79 ± 0.83 (s.e.m.) fluorescent particles in 10 µm 2 cytosol) (Fig. 1f,g ) compared to fasted wild-type and untreated ob/ob values. However, there was no statistically significant difference in POMC DHE levels between fed and DIO mice (Fig. 1f,g ). The lack of difference in POMC ROS levels between fed (lean) and DIO mice was associated with almost threefold higher levels of circulating leptin in DIO mice compared to lean fed mice (Fig. 1h) . Thus, although there is a positive correlation between circulating leptin levels and ROS levels in POMC neurons of fasted and ob/ob mice, in DIO mice substantially higher levels of circulating leptin resulted in no proportional increase in ROS levels in POMC neurons (Fig. 1g,h ). The dissociation of elevated leptin levels from increased POMC ROS content in DIO mice could involve multiple mechanisms, including a putative role for mitochondrial uncoupling protein 2 (UCP2) 1, 15 . We noted the presence of peroxisomes in POMC neurons. Peroxisomes are intracellular organelles involved with non-ATPgenerating lipid beta oxidation and control of ROS 16 . We evaluated the number of mitochondria and peroxisomes in POMC neurons of ob/ob, fasted lean, fed lean and DIO mice. We found the lowest number of mitochondria (0.8 ± 0.06 (s.e.m.) mitochondria per 1 µm 2 cytosol) and peroxisomes (0 peroxisomes per 1 µm 2 cytosol) in the cytosol of POMC in ob/ob mice ( Fig. 2a-c) . Lean fed mice had higher mitochondrial numbers (2.19 ± 0.27 (s.e.m.)) compared to fasted (0.98 ± 0.13 (s.e.m.)) and ob/ob mice ( Fig. 2b) , but peroxisome numbers were not different in fed (0.18 ± 0.04 (s.e.m.)) and fasted mice (0.14 ± 0.01 (s.e.m.)) (Fig. 2c) . Whereas mitochondria numbers were not different in POMC neurons of DIO mice (2.3 ± 0.42 (s.e.m.)) from those in fed mice (Fig. 2b) , peroxisome counts were almost threefold higher in POMC neurons of DIO mice (0.39 ± 0.04 (s.e.m.)) compared to the values of lean fed mice (Fig. 2c) . Through analysis of 50 POMC neurons (ten cells analyzed per mouse; n = 5) 17 , peroxisomes were not found in POMC neurons of db/db mice ( Supplementary Fig. 1 ). We also analyzed peroxisome number in NPY/AgRP neurons. We found that peroxisome number was significantly higher in AgRP neurons of DIO mice compared to lean mice ( Supplementary Fig. 2 ). Taken together, these observations suggest that peroxisomes may render melanocortin neurons less active in DIO mice, decreasing the ability of elevated leptin to promote POMC neuronal activity and satiety.
In mice, proliferation of peroxisomes is governed, in part, by nuclear receptors, such as PPAR-γ (ref. 18 ). PPAR-γ has been associated with brain inflammation, gliosis 19 and ROS control 20 , mechanisms that are characteristic of the arcuate nucleus of DIO mice (present study and refs. 9,21). Additionally, in mice, PPAR-γ has been detected in the brain 22 and in neurons of the arcuate nucleus 23 . We analyzed transcript levels in the hypothalamus of PPAR-α, PPAR-δ and PPAR-γ and some of their putative target genes. PPAR-γ mRNA expression was several fold higher in the hypothalamus compared to PPAR-α or PPAR-δ mRNA in normal-weight wild-type mice (Fig. 2d) . In DIO mice, hypothalamic transcripts of PPAR-γ but not PPAR-α or PPAR-δ were upregulated compared to lean controls (Fig. 2e) . DIO hypothalamus also showed elevated liver X receptor α and glucokinase transcript levels (Fig. 2e) . This constellation of transcript inductions in DIO mice is in line with increased carbohydrate and lipid metabolism in the hypothalamus in response to high-fat feeding and with processes uncovered in the liver 24 . Next, we analyzed PPAR-γ transcript levels in POMC and AgRP neuronal cell lines 25 . PPAR-γ transcripts were identified in both neuronal cultures (Fig. 2f for POMC cultures; data not shown for AgRP cultures). Treatment of the cultures with 10 µM of the PPAR-γ agonist pioglitazone for 24 h resulted in elevated mRNA expression of the PPAR-γ target 26 glycerol-3-phosphate dehydrogenase 1 (Gpd1) in POMC neurons (Fig. 2g) and expression of mRNA encoding fatty acid binding protein 4 (Fabp4) and adipose differentiation-related protein (ADFP or adipophilin) in AgRP neurons (Fig. 2h,i) . Thus, high-fat feeding-inducible hypothalamic PPAR-γ is expressed in key neurons of the melanocortin system, and it can be activated by selective agonists.
In ob/ob hypothalamus, it was PPAR-δ mRNA that was elevated, together with transcripts classically characteristic of preadipocytes such as celldeath-inducing DNA fragmentation factor α-like effector A (CIDEA) 27 and ADFP (Fig. 2j) 28 . Thus, obesity in ob/ob mice has differential cellular pressure on hypothalamic neurons compared to DIO mice.
Next, we tested whether chemical agonists and antagonists of PPAR-γ 29 may affect peroxisome number, ROS levels and feeding in lean and DIO mice. We analyzed lean and DIO mice on high-fat diet, because previous studies 30 , as well as the present study (data not shown), revealed no effect of PPAR-γ agonists or antagonists on feeding of mice on normal chow. We injected lean mice after 5 d on high-fat diet with the PPAR-γ agonist rosiglitazone i.c.v. twice a day for 7 d and DIO mice with 0.5 µg of the PPAR-γ antagonist GW9662 twice a day for 7 d. We i.c.v. injected control mice for both groups (lean mice and DIO mice on high-fat diet) with equivalent volume of the diluent (DMSO in saline). In similar cohorts of mice, we injected DHE in the last day of the treatment to analyze ROS levels in POMC neurons. Seven-day i.c.v. rosiglitazone treatment of lean mice resulted in significantly elevated peroxisome numbers in POMC neurons compared to controls (rosiglitazone: 0.41 ± 0.05 versus vehicle 0.15 ± 0.02; P < 0.05, means ± s.e.m.), which was accompanied by decreased appearance of ROS in these neurons (rosiglitazone: 9.03 ± 0.26; vehicle 17.55 ± 0.4; P < 0.05, means ± s.e.m.) and increased daily food intake (4.28 ± 0.14 g versus 3.43 ± 0.18 g; P < 0.05, means ± s.e.m.) (Fig. 3a-g ). In contrast, 7-d treatment of DIO mice with GW9662 resulted in lower numbers of peroxisomes in POMC neurons compared to controls (GW9662: 0.17 ± 0.02; vehicle: 0.4 ± 0.05; P < 0.05, means ± s.e.m.), with elevated DHE levels (GW9662: 27.45 ± 2.92 fluorescent particles in 10 µm 2 POMC cytosol; vehicle: 18.31 ± 0.66 fluorescent particles in 10 µm 2 POMC cytosol; P < 0.05, means ± s.e.m.) and lower daily food intake (GW9662: 2.29 ± 0.1 g; vehicle: 2.92 ± 0.11 g; P < 0.05, means ± s.e.m.) (Fig. 3a-g ). These observations are consistent with two recent reports showing that interference with neuronal PPAR-γ signaling has no detectable phenotype on standard chow but attenuates DIO 31, 32 .
To further test the relationship between PPAR-γ and peroxisomes, we analyzed the expression of a key peroxisomal enzyme, catalase, in hypothalami of neuron-specific PPAR-γ-knockout mice 31 and wild-type littermates. After 2 weeks on high-fat diet, wild-type mice showed a significantly higher number of catalase-immunopositive arcuate nucleus cells compared to PPAR-γ-knockout mice (51.75 ± 5.75 cells per 0.0025 mm 3 of arcuate nucleus versus 12.75 ± 3.75 cells per 0.0025 mm 3 of arcuate nucleus; P < 0.05; Supplemental Fig. 3) . These data corroborate a role for PPAR-γ in peroxisome proliferation in the hypothalamus. To test whether interference with PPAR-γ activity affects neurobiological correlates of feeding regulation, first we analyzed c-fos expression in POMC neurons of vehicle-, rosiglitazone-and GW9662-treated female mice on high-fat diet. Although rosiglitazone did not affect the number of c-fos-expressing POMC neurons, GW9662 treatment resulted in a significant (P < 0.05) induction of c-fos in melanocortin cells compared to DIO control values (Fig. 3h,i and Supplementary Fig. 4) .
Because GW9662 induced c-fos expression in POMC neurons, and because peroxisome number and PPAR-γ signaling were induced also in NPY neurons, we next analyzed electric activity of NPY/AgRP and POMC neurons in NPY-GFP and POMC-GFP DIO mice with or without GW9662 treatment. The firing rates of NPY/AgRP and POMC neurons were measured on slices taken at 10:00 a.m. from GW9662-or vehicle-treated DIO mice. This time of day represents relative satiety with high POMC and low NPY/AgRP neuronal firing of standard-chow-fed mice 14, 32 . In contrast to standard-chow-fed mice, in vehicle-treated DIO mice, analysis of action potential frequency at 10:00 a.m. revealed high NPY/AgRP neuronal firing and low POMC firing (Fig. 4a,b) . The level of NPY/AgRP neuronal firing in fed DIO mice was not dissimilar from the firing frequency recorded in these neurons during fasting 33 . The low degree of firing of POMC neurons at the time of relative satiety in DIO mice is consistent with the measured lower α-melanocyte-stimulating hormone release by hypothalamic explants of DIO mice 15 . Of note, i.c.v. GW9662 treatment significantly (P < 0.05) reversed this DIO-induced firing alteration of the melanocortin system, whereby NPY/AgRP neurons reduced their firing rate and POMC neurons increased action potential generation (Fig. 4a,b) . In DIO mice, very few NPY/AgRP neurons were silent, but this number was elevated after GW9662 treatment (Fig. 4c) . In contrast, whereas more then half of the POMC neurons were silent (not firing at all) in vehicle-treated DIO mice, this population was smaller after GW9662 treatment (Fig. 4d) . Thus, GW9662 reversed firing of both NPY/AgRP and POMC neurons in DIO mice to resemble the firing rates of these cells in lean mice at a time of satiety on normal chow 15, 33 .
ROS abundance was elevated by GW9662 treatment and readily enhanced POMC neuronal firing (Fig. 1) . To test whether ROS may be a mediator of the effects of PPAR-γ, we next analyzed the effect of rosiglitazone and GW9662 in mice on high-fat diet with and without i.c.v. H 2 O 2 and honokiol administration, respectively. We found that changes in feeding of high-fat-fed mice induced by 7-d treatment with rosiglitazone or GW9662 were diminished by co-administration of H 2 O 2 or honokiol, respectively, between days 5 and 7 (Fig. 4e,f) . Thus, alteration of PPAR-γ signaling may exert its effect on hypothalamic regulation of feeding via ROS. To further test this notion, we analyzed the effect of GW9662 and rosiglitazone in UCP2-knockout mice, which have endogenously elevated hypothalamic ROS levels 1 . We found no significant effect of either GW9662 or rosiglitazone on feeding of these mice (Supplementary Fig. 5 ). The lack of effect of rosiglitazone in UCP-knockout mice is in line with an inhibitory effect of ROS on rosiglitazone. GW9662 may not have been effective because there were very few peroxisomes in POMC neurons of UCP2-knockout mice (Supplementary Fig. 5 ).
To test whether ROS alone could reverse POMC function, we injected H 2 O 2 i.c.v. in DIO mice. We found that i.c.v. H 2 O 2 resulted in elevated c-fos expression in POMC neurons (Fig. 3h,i and Supplementary Fig. 4d ), decreased feeding ( Fig. 4g) and elevated pStat3 expression in response to peripheral leptin injection compared to controls (Fig. 4h) . We found that 3% of POMC neurons (3 out of 100 POMC perikarya from five mice) contained pStat3, whereas in H 2 O 2 -treated DIO mice, 18% of POMC cells (18 out of 100 POMC perikarya from five mice) were immunolabeled for pStat3. These observations suggest that whereas ROS enhances leptin sensitivity in DIO mice, the effects of ROS on feeding may be downstream from leptin signaling, a notion consistent with the electric actions of H 2 O 2 on POMC neurons (Fig. 1) . How other intracellular controllers of ROS interact to set metabolically and functionally relevant cellular ROS levels will need further studies.
This study has established that ROS is an acute activator of POMC neuronal firing and that, in lean mice, hypothalamic ROS is positively correlated with circulating leptin level. ROS levels are controlled in hypothalamic POMC neurons of DIO mice in association with peroxisome proliferation. This previously unrecognized metabolically regulated intracellular mechanism can be regulated by PPAR-γ activity, which itself is under nutritional control in the hypothalamus. Peroxisome proliferation in the hypothalamus is consistent with the origin of peroxisomes from the endoplasmic reticulum under increased metabolic pressure 34, 35 , as endoplasmic reticulum stress has been identified as a contributor to DIO-related leptin resistance 36 . Our results argue for endogenous ROS control during diet-induced obesity as a potential cause of functional leptin resistance, manifested by lower POMC and elevated NPY/AgRP neuronal firing. In light of the deleterious effects of sustained elevated ROS levels 37 , our study gives support to the notion that promotion of sustained satiety through the brain in states of diet-induced obesity may increase degenerative processes 2 .
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